Hyaluronidase bovine injection
What is this medicine?
HYALURONIDASE (hye al ur ON i dase) is a natural protein. It is used to improve the effects of other injectable medicines given with this medicine.
How should I use this medicine?
This medicine is for injection under the skin or into a muscle. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as newborn for selected conditions, precautions do apply.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
fast, irregular heartbeat
feeling faint or lightheaded, falls
nausea or vomiting
swelling at site where injected
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
inflammation, redness or pain at site where injected
What may interact with this medicine?
antihistamines for allergy or cold
aspirin and aspirin-like medicines
benzodiazepines for anxiety or sleep
female hormones like estrogens
steroid medicines like prednisone or cortisone
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
allergy to bee stings or other insects
infection in the area where injection is planned
an unusual or allergic reaction to hyaluronidase, beef proteins, thimerosal, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine. Visit your doctor for check-ups as directed.
September 30, 2017